Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 11 Aug 2020 |
2 | Reply to Exam Report (MIS-R) | 03 Nov 2020 |
3 | Authorization Letter | 01 Aug 2022 |
4 | Documents in support of Show cause Hearing (SCH) | 02 Aug 2022 |
5 | Authorization Letter | 18 Feb 2023 |
5 | Documents in support of Show cause Hearing (SCH) | 18 Feb 2023 |
6 | Authorization Letter | 18 Feb 2023 |
6 | Documents in support of Show cause Hearing (SCH) | 18 Feb 2023 |
7 | Journal Copy | 02 May 2023 |
8 | Certificate | 30 Jul 2023 |
9 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 24 Jul 2024 |
1 | EXAMINATION REPORT | 10355937 | 02 Sep 2020 | |
2 | Hearing Notice (Show Cause) | 12438408 | 09 Nov 2021 | |
3 | Hearing Notice (Show Cause) | 13338254 | 12 Apr 2022 | |
4 | Hearing Notice (Show Cause) | 13738981 | 05 Jul 2022 | |
5 | Hearing Notice (Show Cause) | 14750713 | 06 Feb 2023 | |
6 | Tribunal Accepted Notice for : 4605049 | 14825029 | 5867215 | 20 Feb 2023 |
Trademark was applied on 11 August 2020 with IP India.
Proprietor of Endofert is INTAS PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Endofert is Registered.
Application number alloted to the trademark is 4605049.
Y. J. Trivedi & Co is the Trademark agent/attorney.
Trademark has been filed in the following category:
DEVICE